SCHEMBL4566767

SCHEMBL4566767

CS(=O)(=O)Nc1ccc(CN(C(=O)/C=C\c2ccc(C(F)(F)F)nc2OC2CCOC2)c2ccccc2)cc1F

nearest known ligand 0.43

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 20/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4566768 1.00 TRPV1 (0.43) TRPV1
SCHEMBL3784465 0.84 TRPV1 (0.49) TRPV1
SCHEMBL3784464 0.84 TRPV1 (0.49) TRPV1
SCHEMBL4555350 0.82 TRPV1 (0.46) TRPV1
SCHEMBL4555349 0.82 TRPV1 (0.46) TRPV1
SCHEMBL4554914 0.80 TRPV1 (0.51) TRPV1
SCHEMBL4554915 0.80 TRPV1 (0.51) TRPV1
SCHEMBL3784113 0.73 TRPV1 (0.39) TRPV1
SCHEMBL3784115 0.73 TRPV1 (0.39) TRPV1
SCHEMBL3780240 0.72 SYK (0.39) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054411-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2009-05-06 EP disclosed
WO-2008013414-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2008-01-31 WO disclosed